The importance of IDH mutations in gliomagenesis has made it a target of interest for the treatment of IDH-mutant gliomas.141,142 Multiple IDH inhibitors have been developed, some specific for mutant IDH1, while others inhibit both mutant IDH1 and IDH2. The gene discussed is IDH1; the disease is central nervous system cancer.